Contribuição de grupos de pesquisa brasileiros na avaliação de fármacos para o tratamento da dependência de álcool
Conteúdo do artigo principal
Resumo
Detalhes do artigo
Referências
Baltieri DA. Tratamento farmacológico do alcoolismo. São Paulo: Lemos Editorial; 2005. p.17-61.
Carlini EA, Galduróz JCF, Noto AR, Nappo SA. Levantamento domiciliar de drogas psicotrópicas no Brasil: estudo envolvendo as 107 maiores cidades do país – 2001. São Paulo: CEBRID/ UNIFESP: 2001.
Laranjeira R, Nicastri S, Jeronimo C, Marques AC. Consenso sobre a Síndrome de Abstinência do Álcool (SAA) e o seu tratamento. Rev Bras Psiquiatr. 2000;22(2):62-71. http://dx.doi.org/10.1590/S1516-44462000000200006
Monras M, Freixa N, Ortega L, Lligo-a A, Mondón S, Gual A. Efficacy of group therapy of alcoholics. Results of a controlled clinical trial. Med Clin (Barc). 2000;115(4):126-31. http://dx.doi.org/10.1016/S0025-7753(00)71485-0
Elbreder MF, Silva RS, Pillon SC, Laranjeira R. Alcohol dependence: analysis of factors associated with retention of patients in outpatient treatment. Alcohol Alcohol. 2011;46(1):74-6. http://dx.doi.org/10.1093/alcalc/agq078
Elbreder MF, de Humerez DC, Laranjeira R. The use of disulfiram for alcohol-dependent patients and duration of outpatient treatment. Eur Arch Psychiatry Clin Neurosci. 2010;260(3):191-5. http://dx.doi.org/10.1007/s00406-009-0038-9
Baltieri DA, Daró FR, Ribeiro PL, Andrade AG. The role of alcoholic beverage preference in severity of alcohol dependence and adherence to the treatment. Alcohol. 2009;43(3):185-95. http://dx.doi.org/10.1016/j.alcohol.2009.01.001
Baltieri DA, Daró FR, Ribeiro PL, Andrade AG. Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction. 2008;103(12):2035-44. http://dx.doi.org/10.1111/j.1360-0443.2008.02355.x
Furieri FA, Nakamura-Palacios EM. Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebocontrolled trial. J Clin Psychiatry. 2007;68(11):1691-700. http://dx.doi.org/10.4088/JCP.v68n1108
Baltieri DA, Andrade AG. Efficacy of acamprosate in the treatment of alcohol-dependent outpatients. Rev Bras Psiquiatr. 2003;25(3):156-9. http://dx.doi.org/10.1590/S1516-44462003000300007
Baltieri DA, Andrade AG. Acamprosate in alcohol dependence: a randomized controlled efficacy study in a standard clinical setting. J Stud Alcohol. 2004;65(1):136-9.
Cruz M, Marinho V, Fontenelle LF, Engelhardt E, Laks J. Topiramate may modulate alcohol abuse but not other compulsive behaviors in frontotemporal dementia: case report. Cogn Behav Neurol. 2008;21(2):104-6. http://dx.doi.org/10.1097/WNN.0b013e31816bdf73
Castro LA, Baltieri DA. The pharmacologic treatment of the alcohol dependence. Rev Bras Psiquiatr. 2004;26(Suppl 1):S43-6. http://dx.doi.org/10.1590/S1516-44462004000500011
Jupp B, Lawrence AJ. New horizons for therapeutics in drug and alcohol abuse. Pharmacol Ther. 2010;125(1):138-68. http://dx.doi.org/10.1016/j.pharmthera.2009.11.002
Rueff B. Evaluation of drug treatment of primary alcoholism. Rev Prat. 1999;49(4):400-2.
Johnson BA, Ait-Daoud N. Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients. Curr Pharm Des. 2010;16(19):2103-12. http://dx.doi.org/10.2174/138161210791516404
Edwards S, Kenna GA, Swift RM, Leggio L. Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a review. Curr Pharm Des. 2011; 17(14):1323-32. http://dx.doi.org/10.2174/138161211796150765
Clemens KJ, Vendruscolo LF. Anxious to drink: gabapentin normalizes GABAergic transmission in the central amygdala and reduces symptoms of ethanol dependence. J Neurosci. 2008;10; 28(37):9087-9.